CompletedPhase 2

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

China67 participantsStarted 2018-08-10

Plain-language summary

This single-arm phase II prospective study is to determine the efficacy of early nutritional intervention during concurrent chemoradiotherapy for local advanced non-small cell lung cancer.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed unresectable stage IIIA-IIIC non-small cell lung cancer. * Recieved definitive concurrent chemoradiotherapy. * Pretreatment PG-SGA score A or B. * Eastern Cooperative Oncology Group (ECOG) performance status 0-1. * Estimated life expectancy of at least 6 months. * Without contraindication for chemoradiotherapy. Exclusion Criteria: * Severe impairment of intestinal function, or intolerance of enteral nutrition. * Severe vomiting, gastrointestinal bleeding, or intestinal obstruction. * Severe malnutrition, or intolerance of chemoradiotherapy.

What they're measuring

The incidence of weight loss ≥5% during the treatment

Timeframe: From the start to the end of CCRT

Trial details

NCT IDNCT03673657

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-16

View on ClinicalTrials.gov More Local Advanced Non-small Cell Lung Cancer trials